CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,000 | -6.7% | 20,061 | +60.8% | 0.00% | – |
| Q2 2023 | $15,000 | – | 12,473 | +18242.6% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 68 | -99.1% | 0.00% | – |
| Q1 2022 | $14,000 | -61.1% | 7,612 | -67.3% | 0.00% | – |
| Q4 2021 | $36,000 | +20.0% | 23,284 | +56.9% | 0.00% | – |
| Q3 2021 | $30,000 | +11.1% | 14,842 | +90.5% | 0.00% | – |
| Q2 2021 | $27,000 | – | 7,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 314,000 | $559,000 | 0.11% |
| Inspire Advisors, LLC | 110,787 | $197,000 | 0.07% |
| Horst & Graben Wealth Management LLC | 49,590 | $88,000 | 0.03% |
| Freed Investment Group | 14,600 | $26,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 57,465 | $102,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $89,000 | 0.02% |
| LMR Partners LLP | 63,950 | $114,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 50,356 | $90,000 | 0.00% |
| Renaissance Technologies | 989,096 | $1,761,000 | 0.00% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 20,000 | $36,000 | 0.00% |